Virpax Pharmaceuticals, Inc.
VRPX
$0.30
$0.04417.19%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -83.45% | -99.86% | -87.36% | -89.01% | -51.87% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -80.59% | -89.82% | -18.09% | -21.22% | 11.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -98.91% | -71.99% | -69.84% | -6.95% | -42.90% |
| Total Current Assets | -83.84% | -97.67% | -83.76% | -83.07% | -51.06% |
|
|
|||||
| Total Current Assets | -83.84% | -97.67% | -83.76% | -83.07% | -51.06% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -83.84% | -97.67% | -83.76% | -83.07% | -51.06% |
|
|
|||||
| Total Accounts Payable | 122.16% | 190.06% | -0.92% | -70.58% | -50.80% |
| Total Accrued Expenses | 44.92% | 50.68% | 78.88% | 46.56% | 58.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 25.00% | 25.00% | 200.00% |
| Total Other Current Liabilities | -- | -- | 25.00% | 25.00% | 200.00% |
| Total Current Liabilities | -67.90% | -63.94% | 47.67% | 31.86% | 148.63% |
|
|
|||||
| Total Current Liabilities | -67.90% | -63.94% | 47.67% | 31.86% | 148.63% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -67.90% | -63.94% | 47.67% | 31.86% | 148.63% |
|
|
|||||
| Common Stock & APIC | 15.00% | 7.61% | 3.47% | 0.78% | 0.89% |
| Retained Earnings | -20.27% | -24.08% | -35.17% | -36.82% | -34.25% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -147.24% | -131.54% | -122.71% | -107.98% | -88.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -147.24% | -131.54% | -122.71% | -107.98% | -88.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -147.24% | -131.54% | -122.71% | -107.98% | -88.33% |
|
|
|||||